SMTL ID : 3e4a.1 (1 other biounit)

Human IDE-inhibitor complex at 2.6 angstrom resolution

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.60 Å

Oligo State

monomer

Ligands

1 x ALA- ALA- ALA: HYDROXAMATE PEPTIDE II1(Non-covalent)

ALA-ALA-ALA.1: 7 residues within 4Å: Chain A: G.335, G.339, E.341, L.359, G.361, G.362, Y.609 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:G.361

1 x ZN: ZINC ION(Non-covalent)

ZN.2: 4 residues within 4Å: Chain A: H.108, H.112, E.189 Ligands: QIX.3 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:H.108, A:H.112, A:E.189, A:E.189

1 x QIX: N~2~-[(2R)-4-(HYDROXYAMINO)-2-(2-NAPHTHYLMETHYL)-4-OXOBUTANOYL]-L-ARGINYLGLYCYLGLYCINAMIDE(Non-covalent)

QIX.3: 17 residues within 4Å: Chain A: H.108, Q.111, H.112, F.115, L.116, S.128, N.139, A.140, E.182, E.189, E.817, F.820, R.824, T.825, Y.831, I.832 Ligands: ZN.2 17 PLIP interactions: 17 interactions with chain A Hydrophobic interactions: A:F.115, A:L.116, A:F.820, A:F.820 Hydrogen bonds: A:Q.111, A:S.128, A:S.128, A:N.139, A:N.139, A:A.140, A:R.824, A:R.824, A:Y.831 Water bridges: A:T.142, A:T.142 pi-Stacking: A:F.115 pi-Cation interactions: A:F.820

2 x DIO: 1,4-DIETHYLENE DIOXIDE(Non-covalent)

DIO.4: 5 residues within 4Å: Chain A: Q.800, E.910, S.913, R.920 Ligands: DIO.5 No protein-ligand interaction detected (PLIP) DIO.5: 8 residues within 4Å: Chain A: Q.800, R.839, A.840, N.841, G.842, S.913, Q.915 Ligands: DIO.4 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:Q.800, A:N.841, A:G.842

8 x ACY: ACETIC ACID(Non-functional Binders)

ACY.6: 3 residues within 4Å: Chain A: K.558, Y.916, H.1011 1 PLIP interactions: 1 interactions with chain A Salt bridges: A:K.558 ACY.7: 2 residues within 4Å: Chain A: K.119, K.120 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:K.119 Salt bridges: A:K.120 ACY.8: 1 residues within 4Å: Chain A: E.290 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:E.290 Water bridges: A:E.290 ACY.9: 3 residues within 4Å: Chain A: P.461, D.462, E.465 No protein-ligand interaction detected (PLIP) ACY.10: 4 residues within 4Å: Chain A: E.990, F.998, G.1001, L.1002 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:L.1002 Hydrogen bonds: A:G.1001 ACY.11: 2 residues within 4Å: Chain A: E.529, F.530 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:E.529 Hydrogen bonds: A:Y.607 ACY.12: 6 residues within 4Å: Chain A: N.312, T.358, V.360, N.376, V.377, D.378 1 PLIP interactions: 1 interactions with chain A Hydrophobic interactions: A:V.360 ACY.13: 7 residues within 4Å: Chain A: L.204, E.205, T.208, Y.302, I.304, R.477, A.479 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:E.205 Hydrogen bonds: A:R.477

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Leissring, M.A. et al., Designed inhibitors of insulin-degrading enzyme regulate the catabolism and activity of insulin. Plos One (2010)

Release Date

2009-05-19

Peptides

Insulin-degrading enzyme: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Insulin-degrading enzyme

Related Entries With Identical Sequence